💪🧬🥇2024 / 9th INTERNATIONAL PEER-REVIEWED PUBLICATIONS – EX VIVO CLINICAL APPROACH – CLINIC’N’CELL

https://pubmed.ncbi.nlm.nih.gov/38543230/

Pharmaceutics. 2024 Feb 28;16(3):336. doi: 10.3390/pharmaceutics16030336.

Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake

Line Pourtau 1, Fabien Wauquier 2, Line Boutin-Wittrant 2, David Gaudout 1, Benjamin Moras 1, Adeline Vignault 1, Carole Vaysse 3, Tristan Richard 4 5, Arnaud Courtois 4 5, Stéphanie Krisa 4 5, Véronique Roux 6, Nicolas Macian 6, Gisèle Pickering 6, Yohann Wittrant 2 7 8

💪🧬🥇2024 / 8th INTERNATIONAL PEER-REVIEWED PUBLICATIONS TO ATTEST THE ROBUSTNESS AND EFFICIENCY OF EX VIVO CLINICAL APPROACH – CLINIC’N’CELL

https://pubmed.ncbi.nlm.nih.gov/37735385/

Randomized Controlled Trial

BMC Musculoskelet Disord. 2023 Sep 21;24(1):748. doi:10.1186/s12891-023-06800-4.

Oral supplementation with fish cartilage hydrolysate in an adult population suffering from knee pain and function discomfort: results from an innovative approach combining an exploratory clinical study and an ex vivo clinical investigation

Henrotin Yves 1 2, Julie Herman 3, Melanie Uebelhoer 3, Fabien Wauquier 4, Line Boutin-Wittrant 4, Anne-Françoise Donneau 5, Justine Monseur 5, Variance Mokam Fotso 3, Marie Duquenne 6, Mélanie Wagner 7, Elodie Bouvret 8, Bérénice Costes 3, Yohann Wittrant 9 10